Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
29.20
+0.40 (1.39%)
Jul 28, 2026, 2:49 PM EDT - Market open
Genmab Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 17,751 | 19,785 | 13,813 | 21,038 | 27,955 | 25,998 | |
Market Cap Growth | 17.25% | 43.23% | -34.34% | -24.74% | 7.52% | -2.45% |
Enterprise Value | 21,532 | 23,496 | 11,003 | 16,986 | 24,827 | 23,106 |
Last Close Price | 29.20 | 30.80 | 20.87 | 31.84 | 42.38 | 39.56 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 21.62 | 20.04 | 11.91 | 33.24 | 35.61 | 58.18 |
PS Ratio | 4.55 | 5.32 | 4.43 | 8.80 | 13.39 | 20.20 |
PB Ratio | 3.12 | 3.38 | 2.69 | 4.50 | 7.12 | 7.66 |
P/TBV Ratio | - | - | 4.42 | 4.50 | 7.16 | 7.79 |
P/FCF Ratio | 20.36 | 17.22 | 12.57 | 20.67 | 54.02 | 86.03 |
P/OCF Ratio | 19.68 | 16.68 | 12.27 | 19.64 | 49.65 | 76.30 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 5.52 | 6.32 | 3.53 | 7.11 | 11.89 | 17.95 |
EV/EBITDA Ratio | 19.22 | 20.68 | 10.66 | 20.84 | 26.02 | 47.20 |
EV/EBIT Ratio | 20.37 | 22.06 | 11.32 | 22.00 | 27.52 | 51.17 |
EV/FCF Ratio | 24.69 | 20.45 | 10.01 | 16.69 | 47.98 | 76.46 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.89 | 0.88 | 0.03 | 0.02 | 0.02 | 0.02 |
Debt / EBITDA Ratio | 4.78 | 4.78 | 0.14 | 0.14 | 0.09 | 0.13 |
Debt / FCF Ratio | 9.16 | 4.72 | 0.13 | 0.11 | 0.17 | 0.22 |
Net Debt / Equity Ratio | 0.67 | 0.64 | -0.55 | -0.87 | -0.80 | -0.85 |
Net Debt / EBITDA Ratio | 3.42 | 3.27 | -2.72 | -4.97 | -3.28 | -5.91 |
Net Debt / FCF Ratio | 6.56 | 3.23 | -2.56 | -3.98 | -6.04 | -9.57 |
Asset Turnover | 0.31 | 0.39 | 0.54 | 0.50 | 0.52 | 0.36 |
Inventory Turnover | 13.38 | 17.63 | 16.40 | 7.82 | - | - |
Quick Ratio | 2.17 | 2.01 | 5.23 | 13.32 | 15.48 | 14.50 |
Current Ratio | 2.18 | 2.02 | 5.24 | 13.34 | 15.48 | 14.50 |
Return on Equity (ROE) | 12.79% | 17.53% | 23.08% | 14.66% | 21.44% | 13.84% |
Return on Assets (ROA) | 6.82% | 8.83% | 14.27% | 12.47% | 17.48% | 9.42% |
Return on Invested Capital (ROIC) | 9.03% | 14.33% | 56.20% | 83.50% | 108.81% | 64.69% |
Return on Capital Employed (ROCE) | 9.34% | 12.44% | 18.47% | 17.29% | 23.74% | 13.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.63% | 4.99% | 8.40% | 3.01% | 2.81% | 1.72% |
FCF Yield | 4.91% | 5.81% | 7.96% | 4.84% | 1.85% | 1.16% |
Buyback Yield / Dilution | 2.55% | 3.04% | 1.88% | 0.17% | 0.05% | -0.24% |
Total Shareholder Return | 2.55% | 3.04% | 1.88% | 0.17% | 0.05% | -0.24% |